Answers are grounded in this paper and cite their sources.
Multimodal approaches using artificial intelligence in clinical trials improve long-term outcomes for endometriosis management.
Hormonal suppression remains the cornerstone of treatment, but novel nonhormonal strategies and advances in precision medicine hold promise for more durable and individualized care. Ongoing clinical trials, artificial intelligence - assisted diagnostics, and fertility-focused pharmacotherapies represent exciting frontiers. Multimodal, patient-tailored approaches will be key to optimizing long-term outcomes in endometriosis management.
No takes yet. Share an insight, caveat, or question.
Imbroane et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: